On November 10, Dr. Gene Hung, Founder and Chief Scientific Officer of RayThera, Inc., visited Medicilon’s Nanhui campus to further strengthen strategic collaboration and recognize outstanding achievements. During the visit, RayThera presented Medicilon with the “Excellent Partnership Award”, the Chemistry FTE Team with the “Excellent Service Team Award”, and Dr. Zhu Du, Vice President of Chemistry, with the “Leadership Award”.
Senior leadership representatives including Dr. Maosheng Duan (President of Drug Discovery and CMC Divisions), Dr. Jian Ge (Executive Vice President of Preclinical Research), Dr. Baohong Cao (Vice President of Pharmacology), and Dr. Zhu Du attended the meeting and the award ceremony.
The recognition reflects the strong partnership cultivated over the past two years in pharmaceutical chemistry services. Medicilon’s dedicated FTE team worked closely with RayThera, deploying resources efficiently, even during holidays, to ensure milestones were delivered ahead of schedule. Their scientific expertise, responsiveness, and high-level service earned strong endorsement from the RayThera team.
Following the ceremony, both companies engaged in technical discussions focused on preclinical development, in vitro biology research, and immuno-oncology models. Medicilon highlighted its integrated end-to-end platform, reinforcing a foundation for expanded collaboration moving forward.
Dr. Gene Hung shared:
“Medicilon’s scientific rigor, proactive project management, and innovative problem-solving continue to make them a trusted partner. We look forward to accelerating breakthrough therapy development together.”
Dr. Maosheng Duan commented:
“We are honored by RayThera’s recognition. This award represents our shared commitment to tackling R&D challenges. Medicilon will continue to leverage its global experience and robust capabilities to support partners with high-quality, efficient services.”
Medicilon remains committed to advancing strong client partnerships that drive progress in global drug discovery and development.
